BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 21613919)

  • 1. Menopausal hormone therapy: what we know now.
    Roush K
    Am J Nurs; 2011 Jun; 111(6):38-47; quiz 48-9. PubMed ID: 21613919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. After the Women's Health Initiative: decision making and trust of women taking hormone therapy.
    Schonberg MA; Davis RB; Wee CC
    Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle risk management--a qualitative analysis of women's descriptions of taking hormone therapy following surgically induced menopause.
    Crowe M; Burrell B; Whitehead L
    J Adv Nurs; 2012 Aug; 68(8):1814-23. PubMed ID: 22082259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compounded or confused? Bioidentical hormones and menopausal health.
    Huntley AL
    Menopause Int; 2011 Mar; 17(1):16-8. PubMed ID: 21427420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.
    Sveinsdóttir H; Olafsson RF
    J Adv Nurs; 2006 Jun; 54(5):572-84. PubMed ID: 16722955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on hormones, menopause, and heart disease: evaluating professional responses to the Women's Health Initiative.
    Derry PS
    Health Care Women Int; 2008 Aug; 29(7):720-37. PubMed ID: 18663631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of compounded bioidentical hormone therapy in menopausal women: an opinion statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
    McBane SE; Borgelt LM; Barnes KN; Westberg SM; Lodise NM; Stassinos M
    Pharmacotherapy; 2014; 34(4):410-23. PubMed ID: 24390902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP
    Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging facade of menopausal hormone therapy.
    Rees M
    Semin Reprod Med; 2010 Sep; 28(5):351-9. PubMed ID: 20845235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
    Stefanick ML
    Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy: women's decision-making process.
    Jones JB
    Soc Work Health Care; 1999; 28(3):95-111. PubMed ID: 10457983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
    Langer RD
    Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.